- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
Second Chance for NIH Grant Applicants
10 February 2011 5:10 pm
Did you miss the funding cutoff despite a stellar score on your U.S. National Institutes of Health (NIH) grant? Don't give up hope. The National Health Council (NHC), a Washington, D.C.-based nonprofit umbrella group for some 100 patient-advocacy groups and companies, unveiled a database on Monday that will hook up rejected projects and potential funders.
The site, called Health Research Funding, is meant to be "the Match.com of funding organizations," says NHC spokesperson Emily Noonan. Any researcher who had a proposal that NIH deemed worthy of peer review but didn't fund can post their abstract and contact information for no cost. Registered funding organizations (but no one else) will be able to troll the abstracts for projects they like.
Right now, the site has info from just the 42 patient-advocacy groups, such as the American Cancer Society and the Alzheimer's Association. Companies may be added later, possibly for a fee, says Nancy Hughes, NHC assistant vice president for communications and marketing.
NHC proposed the database more than 3 years ago, but it took a while to round up the funding ($112,000 split roughly between Pfizer and NIH) and to build the database, Hughes says. On her blog, NIH extramural researcher chief Sally Rockey called it "good news on the where-am-I-going-to-get-my-grant-funded-in-today's-economy front."